Therefore, our findings emphasize the potential of high throughput screening approaches to identify novel YAP/TAZ regulators, and how this strategy can be further used to uncover new targets that may be appropriate for development into a cancer therapeutic. The gene discussed is YAP1; the disease is cancer.